Tema ETFs’s 10x Genomics TXG Stock Holding History

Tema ETFs’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$943K	Buy	+10,432	New	+$610K	0.04%	298

Other funds holding TXG

Counterpoint Mutual Funds San Diego, California $1.16B AUM 33.78% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return

TWM

TriaGen Wealth Management Calabasas, California $413M AUM 35.91% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return

Frank Rimerman Advisors Palo Alto, California $1.81B AUM 32.96% 1-Year Est. Return

Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return

Tema ETFs's TXG Position: Q3 2026 in Review

Tema ETFs opened a new position in 10x Genomics (TXG) in Q3 2026: 10,432 shares worth $943K. The stake represents 0.04% of the portfolio and ranks #298 among its holdings.

42 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

Tema ETFs held 10,432 shares of 10x Genomics worth $943K as of Q3 2026.
10x Genomics was a new Tema ETFs position in Q3 2026.
10x Genomics made up 0.04% of Tema ETFs's portfolio in Q3 2026, its #298 holding.
42 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.